VALIANT LABORATORIES
Back to Income Statement
|
VALIANT LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Net Sales | ₹237 Cr | ₹133 Cr | ₹182 Cr | ₹334 Cr |
What is the latest Revenue of VALIANT LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹237 Cr |
| Mar2025 | ₹133 Cr |
| Mar2024 | ₹182 Cr |
| Mar2023 | ₹334 Cr |
How is Revenue of VALIANT LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹237 Cr | 78.04 | |
| Mar2025 | ₹133 Cr | -26.74 | |
| Mar2024 | ₹182 Cr | -45.48 | |
| Mar2023 | ₹334 Cr | - | |
Compare Revenue of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹560.6 Cr | -7.7% | -24.8% | 24.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -7.7% |
-24.8% |
24.4% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses